Taskforce makes conditional recommendation for use of sotrovimab
26 August, 2021
The National COVID-19 Clinical Evidence Taskforce today published three recommendations on the use of sotrovimab for the treatment of COVID-19 in adults who do not require oxygen and who have risk factors for disease progression. These are the first recommendations from the Taskforce to use a drug to treat patients with mild illness. The Taskforce updated the sotrovimab recommendation after...